Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Bio-Vascular

This article was originally published in The Gray Sheet

Executive Summary

Bio-Vascular: Plans first quarter 1998 launch of its Ocu-Guard wrapping material for ophthalmic implants following 510(k) clearance, announced Dec. 31. The bovine pericardium-derived wrapping is indicated for use with ophthalmic orbital implants following enucleation surgery. By decreasing the likelihood of exposure to the implant material and allowing for reattachment of eye muscles to the implant, Ocu-Guard provides a prosthetic eye with "complete tracking abilities," the St. Paul, Minnesota firm claims...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009353

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel